Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related
| dc.contributor.author | Valls Rodríguez, Andrea | |
| dc.contributor.author | Ruiz Roldán, Cristina | |
| dc.contributor.author | Immanuel, Jenita | |
| dc.contributor.author | Camaño González, Pilar | |
| dc.contributor.author | Poza Aldea, Juan José | |
| dc.contributor.author | Fernández Torrón, Roberto | |
| dc.contributor.author | López de Munain Arregui, Adolfo | |
| dc.contributor.author | Sáenz, Amets | |
| dc.date.accessioned | 2025-09-24T11:00:39Z | |
| dc.date.available | 2025-09-24T11:00:39Z | |
| dc.date.issued | 2025-05-13 | |
| dc.date.updated | 2025-09-24T11:00:39Z | |
| dc.description.abstract | We aimed to investigate the validity of urinary N-terminal titin (TTN) fragment as a biomarker for limb-girdle muscular dystrophy LGMDR1-calpain 3 related. Thirteen LGMDR1 patients and eleven healthy controls were enrolled for the study. LGMDR1 patients had significantly increased urinary N-terminal titin fragment concentrations than age-matched controls. Even if urinary level of titin decreased with aging, it was still high in wheelchair bound patients. Thus, our findings indicate that urinary N-terminal titin fragment is a non-invasive measure of muscle damage in LGMDR1, which could be used in disease monitoring in clinical trials even in wheelchair-bound patients. | en |
| dc.description.sponsorship | This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project “PI21/00047” and co-funded by the European Union. It has been funded also by Department of Health of the Government of the Basque Country (project ref 2021111022 and 2024111043) and Association Française contre les Myopathies (AFM 24743). This work was, in part, supported by the Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED: CB06/05/1126 to Andrea Valls, Pilar Camaño, Adolfo López de Munain, and Amets Sáenz), GENE (Association of Neuromuscular disease of Gipuzkoa) | en |
| dc.identifier.citation | Valls, A., Ruiz-Roldán, C., Immanuel, J., Camaño, P., Poza, J. J., Fernández-Torrón, R., López de Munain, A., & Sáenz, A. (2025). Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related. Journal of neuromuscular diseases, 12(5), 683-688. https://doi.org/10.1177/22143602251323629 | |
| dc.identifier.doi | 10.1177/22143602251323629 | |
| dc.identifier.eissn | 2214-3602 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14454/3729 | |
| dc.language.iso | eng | |
| dc.publisher | Sage | |
| dc.subject.other | Biomarker | |
| dc.subject.other | Calpain 3 | |
| dc.subject.other | Clinical trial | |
| dc.subject.other | LGMDR1 | |
| dc.subject.other | Phenotype severity | |
| dc.title | Urinary N-terminal titin fragment ascertained as biomarker in a small cohort of limb-girdle muscular dystrophy LGMDR1-calpain 3 related | en |
| dc.type | journal article | |
| dcterms.accessRights | open access | |
| oaire.citation.endPage | 688 | |
| oaire.citation.issue | 5 | |
| oaire.citation.startPage | 683 | |
| oaire.citation.title | Journal of neuromuscular diseases | |
| oaire.citation.volume | 12 | |
| oaire.licenseCondition | https://creativecommons.org/licenses/by-nc/4.0/ | |
| oaire.version | VoR |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- valls_urinary_2025.pdf
- Tamaño:
- 693.92 KB
- Formato:
- Adobe Portable Document Format